These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 23704908

  • 1. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
    Mu X, Lin S, Yang J, Chen C, Chen Y, Herzig MC, Washburn K, Halff GA, Walter CA, Sun B, Sun LZ.
    PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
    [Abstract] [Full Text] [Related]

  • 2. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
    Wang Y, Wu J, Lin B, Li X, Zhang H, Ding H, Chen X, Lan L, Luo H.
    Toxicology; 2014 Dec 04; 326():9-17. PubMed ID: 25268046
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M, Baer HU, Friess H, Berberat P, Zimmermann A, Graber H, Gold LI, Korc M, Büchler MW.
    Am J Surg; 1999 Mar 04; 177(3):209-15. PubMed ID: 10219856
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
    Dzieran J, Fabian J, Feng T, Coulouarn C, Ilkavets I, Kyselova A, Breuhahn K, Dooley S, Meindl-Beinker NM.
    PLoS One; 2013 Mar 04; 8(8):e72252. PubMed ID: 23991075
    [Abstract] [Full Text] [Related]

  • 6. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H, Ju HL, Chung SI, Cho KJ, Eun JW, Nam SW, Han KH, Calvisi DF, Ro SW.
    Gastroenterology; 2017 Nov 04; 153(5):1378-1391.e6. PubMed ID: 28734833
    [Abstract] [Full Text] [Related]

  • 7. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
    Yan X, Wu J, Jiang Q, Cheng H, Han JJ, Chen YG.
    J Mol Cell Biol; 2018 Feb 01; 10(1):48-59. PubMed ID: 29036306
    [Abstract] [Full Text] [Related]

  • 8. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ, Wang XH, Miao L, Liu Z, Zhang P, Zhang FM, Yang JB.
    World J Gastroenterol; 2006 Jan 28; 12(4):644-8. PubMed ID: 16489684
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q, Liu G, Shao D, Wang J, Yuan H, Chen T, Zhai R, Ni W, Tai G.
    Int J Biochem Cell Biol; 2015 Feb 28; 59():116-25. PubMed ID: 25526895
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
    Chen J, Zhu H, Liu Q, Ning D, Zhang Z, Zhang L, Mo J, Du P, Liu X, Song S, Fan Y, Liang H, Liu J, Zhang B, Chen X.
    J Exp Clin Cancer Res; 2019 Jun 22; 38(1):273. PubMed ID: 31228948
    [Abstract] [Full Text] [Related]

  • 15. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
    Baek JY, Morris SM, Campbell J, Fausto N, Yeh MM, Grady WM.
    Int J Cancer; 2010 Sep 01; 127(5):1060-71. PubMed ID: 20020490
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
    Jiang F, Mu J, Wang X, Ye X, Si L, Ning S, Li Z, Li Y.
    PLoS One; 2014 Sep 01; 9(5):e96698. PubMed ID: 24806207
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
    Yang J, Zhang X, Liu L, Yang X, Qian Q, Du B.
    Life Sci; 2021 Jan 01; 264():118711. PubMed ID: 33186566
    [Abstract] [Full Text] [Related]

  • 20. miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway.
    Zhang J, Zhu Y, Hu L, Yan F, Chen J.
    Sci Rep; 2019 May 10; 9(1):7213. PubMed ID: 31076630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.